Achievement of Very Low Disease Activity and Remission Treatment Targets Is Associated with Reduced Radiographic Progression in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol

被引：0
|
作者：
Coates, Laura [1 ]
Merola, Joseph [2 ]
Kavanaugh, Arthur [3 ]
Mease, Philip [4 ,5 ]
Davies, Owen [6 ]
Irvin-Sellers, Oscar [6 ]
Nurminen, Tommi [7 ]
van der Heijde, Desiree [8 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[4] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] UCB Pharma, Slough, Berks, England
[7] UCB Pharma, Monheim, Germany
[8] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1535
引用
收藏
页数：4
相关论文
共 50 条
  • [1] ACHIEVEMENT OF VERY LOW DISEASE ACTIVITY AND REMISSION TREATMENT TARGETS IS ASSOCIATED WITH REDUCED RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
    Coates, L. C.
    Merola, J. F.
    Kavanaugh, A.
    Mease, P. J.
    Davies, O.
    Irvin-Sellers, O.
    Nurminen, T.
    Van der Heijde, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 754 - 755
  • [2] ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS
    Coates, Laura C.
    Merola, Joseph F.
    Fitzgerald, Oliver
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Tillett, William
    Bauer, Lars
    Hoepken, Bengt
    Nurminen, Tommi
    Mease, Philip J.
    Helliwell, Philip
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1836 - 1837
  • [3] Achievement of Remission Is Associated with Improvement in Functionality in Certolizumab Pegol-Treated Patients with Psoriatic Arthritis, Irrespective of Pre-Existing Radiographic Structural Damage
    Coates, Laura
    van der Heijde, Desiree
    Kristensen, Lars Erik
    Tillett, William
    Eells, Jason
    Nurminen, Tommi
    Deodhar, Atul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] THE EFFECT OF CERTOLIZUMAB PEGOL ON RADIOGRAPHIC PROGRESSION OVER 4 YEARS OF TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS
    van der Heijde, D.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Bauer, L.
    Hoepken, B.
    Peterson, L.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1316 - 1316
  • [5] Comprehensive Disease Remission Achieved By Certolizumab Pegol Treatment, and Factors Associated With Certolizumab Pegol Comprehensive Disease Remission, In Rheumatoid Arthritis Patients With Predominantly High Disease Activity
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Okamoto, Tadao
    Wada, Yumiko
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S990 - S990
  • [6] Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
    Paul, Stephane
    Marotte, Hubert
    Kavanaugh, Arthur
    Goupille, Philippe
    Kvien, Tore K.
    de Longueville, Marc
    Mulleman, Denis
    Sandborn, William J.
    Vande Casteele, Niels
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 743 - 751
  • [7] CERTOLIZUMAB PEGOL PROVIDES SUSTAINED REMISSION AND MINIMAL DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS OVER 4 YEARS' TREATMENT
    van der Heijde, D.
    Deodhar, A.
    FitzGerald, O.
    Fleischmann, R.
    Gladman, D.
    Gottlieb, A. B.
    Coates, L. C.
    Hoepken, B.
    Bauer, L.
    Peterson, L.
    Khraishi, M.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1027 - 1027
  • [8] Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
    Ennio Lubrano
    Fabio Massimo Perrotta
    Silvia Scriffignano
    Laura C. Coates
    Philip Helliwell
    [J]. Rheumatology and Therapy, 2019, 6 : 521 - 528
  • [9] Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    Scriffignano, Silvia
    Coates, Laura C.
    Helliwell, Philip
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 521 - 528
  • [10] Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
    Coates, Laura
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen
    Nantel, Francois
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 995 - 995
12345